TY  - JOUR
AU  - Šefer, Dijana
AU  - Miljić, Predrag
AU  - Kraguljac-Kurtović, Nada
AU  - Bižić-Radulović, Sandra
AU  - Bogdanović, Andrija
AU  - Knežević, Vesna
AU  - Marković, Dragana
AU  - Beleslin-Čokić, Bojana
AU  - Novaković, Ivana
AU  - Marinković, Jelena
AU  - Leković, Danijela
AU  - Gotić, Mirjana
AU  - Čokić, Vladan
PY  - 2022
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/1231
AB  - Introduction: The impact of activated blood and endothelial cells on the thrombosis in myeloproliferative neoplasms (MPN) has not yet been clarified. We prospectively analyzed correlation between circulating leukocyte-platelet aggregates and soluble selectins to thrombosis occurrence in MPN, in the context of standard and cardiovascular risk factors, and different clinical and biological characteristics. Methods: Flow cytometric analysis of neutrophil-platelet (Neu-Plt) and monocyte-platelet (Mo-Plt) aggregates in peripheral blood, as well as quantification of soluble E-/L-/P-selectins by enzyme immunoassay, was performed on 95 newly diagnosed MPN patients. Results: During the follow-up, thrombosis occurred in 12.6% MPN patients (arterial 9.4%, venous 3.2%), with a mean time of 39 months. The overall incidence rate of main thrombotic events was 4.36 per 100 patient-years. The incidence of arterial hypertension (HTA) was significantly higher in patients with thrombosis, compared to those without thrombosis (P <.05). The level of soluble P-selectin was significantly higher in patients with thrombosis compared to those without thrombosis (346.89 ng/mL vs 286.39 ng/mL, P =.034). The mean level of Neu-Plt (26.7% vs 22.4%) and Mo-Plt (17.8% vs 12.3%) aggregates did not differ significantly between the groups with and without thrombosis. A multivariate COX proportional hazard regression model confirmed an independent predictive significance of Mo-Plt aggregates (HR = 1.561, 95% CI: 1.007-2.420, P =.046), as well as the cumulative effect of Mo-Plt aggregates and HTA (HR = 1.975, 95%CI: 1.215-3.212, P =.006) for thrombosis occurrence. Conclusion: Monocyte-platelet aggregates represent an independent risk factor for thrombosis occurrence, further on supported by HTA.
T2  - International Journal of Laboratory Hematology
T1  - Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms
EP  - 312
IS  - 2
SP  - 302
VL  - 44
DO  - 10.1111/ijlh.13754
ER  - 

@article{
author = "Šefer, Dijana and Miljić, Predrag and Kraguljac-Kurtović, Nada and Bižić-Radulović, Sandra and Bogdanović, Andrija and Knežević, Vesna and Marković, Dragana and Beleslin-Čokić, Bojana and Novaković, Ivana and Marinković, Jelena and Leković, Danijela and Gotić, Mirjana and Čokić, Vladan",
year = "2022",
abstract = "Introduction: The impact of activated blood and endothelial cells on the thrombosis in myeloproliferative neoplasms (MPN) has not yet been clarified. We prospectively analyzed correlation between circulating leukocyte-platelet aggregates and soluble selectins to thrombosis occurrence in MPN, in the context of standard and cardiovascular risk factors, and different clinical and biological characteristics. Methods: Flow cytometric analysis of neutrophil-platelet (Neu-Plt) and monocyte-platelet (Mo-Plt) aggregates in peripheral blood, as well as quantification of soluble E-/L-/P-selectins by enzyme immunoassay, was performed on 95 newly diagnosed MPN patients. Results: During the follow-up, thrombosis occurred in 12.6% MPN patients (arterial 9.4%, venous 3.2%), with a mean time of 39 months. The overall incidence rate of main thrombotic events was 4.36 per 100 patient-years. The incidence of arterial hypertension (HTA) was significantly higher in patients with thrombosis, compared to those without thrombosis (P <.05). The level of soluble P-selectin was significantly higher in patients with thrombosis compared to those without thrombosis (346.89 ng/mL vs 286.39 ng/mL, P =.034). The mean level of Neu-Plt (26.7% vs 22.4%) and Mo-Plt (17.8% vs 12.3%) aggregates did not differ significantly between the groups with and without thrombosis. A multivariate COX proportional hazard regression model confirmed an independent predictive significance of Mo-Plt aggregates (HR = 1.561, 95% CI: 1.007-2.420, P =.046), as well as the cumulative effect of Mo-Plt aggregates and HTA (HR = 1.975, 95%CI: 1.215-3.212, P =.006) for thrombosis occurrence. Conclusion: Monocyte-platelet aggregates represent an independent risk factor for thrombosis occurrence, further on supported by HTA.",
journal = "International Journal of Laboratory Hematology",
title = "Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms",
pages = "312-302",
number = "2",
volume = "44",
doi = "10.1111/ijlh.13754"
}

Šefer, D., Miljić, P., Kraguljac-Kurtović, N., Bižić-Radulović, S., Bogdanović, A., Knežević, V., Marković, D., Beleslin-Čokić, B., Novaković, I., Marinković, J., Leković, D., Gotić, M.,& Čokić, V.. (2022). Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms. in International Journal of Laboratory Hematology, 44(2), 302-312.
https://doi.org/10.1111/ijlh.13754

Šefer D, Miljić P, Kraguljac-Kurtović N, Bižić-Radulović S, Bogdanović A, Knežević V, Marković D, Beleslin-Čokić B, Novaković I, Marinković J, Leković D, Gotić M, Čokić V. Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms. in International Journal of Laboratory Hematology. 2022;44(2):302-312.
doi:10.1111/ijlh.13754 .

Šefer, Dijana, Miljić, Predrag, Kraguljac-Kurtović, Nada, Bižić-Radulović, Sandra, Bogdanović, Andrija, Knežević, Vesna, Marković, Dragana, Beleslin-Čokić, Bojana, Novaković, Ivana, Marinković, Jelena, Leković, Danijela, Gotić, Mirjana, Čokić, Vladan, "Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms" in International Journal of Laboratory Hematology, 44, no. 2 (2022):302-312,
https://doi.org/10.1111/ijlh.13754 . .

TY  - JOUR
AU  - Šefer, Dijana
AU  - Bižić-Radulović, Sandra
AU  - Kraguljac-Kurtović, Nada
AU  - Bogdanović, Andrija
AU  - Čokić, Vladan
AU  - Miljić, Predrag
AU  - Beleslin-Čokić, Bojana
AU  - Knežević, Vesna
AU  - Mitrović-Ajtić, Olivera
AU  - Leković, Danijela
AU  - Gotić, Mirjana
PY  - 2017
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/795
AB  - Introduction: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are characterized by overproduction of one or more blood cell lines. Methods: We studied the proliferative characteristics of 91 patients with de novo Ph-MPN. Colony-forming cells (CFC) and endogenous colonies (EC), from bone marrow (BM) and/or peripheral blood (PB), were analyzed by colony assay based on methylcellulose. The level of circulating CD34(+) cells was determined by flow cytometry. Results: The total number of PB CFC in primary myelofibrosis (PMF) was increased compared to the control sample (P  lt  0.01) and essential thrombocythemia (ET) (P  lt  0.05). The highest number of BM and PB EC was observed in polycythemia vera (PV) (P  lt  0.01). Increased levels of CD34(+) cells characterized early-prefibrotic (57%) and advanced-fibrotic PMF (90%) as compared to PV (34%) and ET (32%) (P  lt  0.01). In the whole Ph-MPN group, the total number of PB CFC (P  lt  0.01), PB EC (P  lt  0.05), and CD34+ cells (P  lt  0.01) correlated with the degree of BM fibrosis. Higher levels of circulating CD34(+) cells in PMF correlated with the total number of PB EC (P  lt  0.05) and degree of BM fibrosis (P  lt  0.01). Conclusions: Exploration of the PB proliferative characteristics of Ph-MPN on diagnosis may be helpful in revealing early-prefibrotic PMF. Monitoring the levels of circulating CD34(+) cells may provide a sensitive indicator of fibrotic evolution in PV and PMF.
PB  - Wiley, Hoboken
T2  - International Journal of Laboratory Hematology
T1  - Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications
EP  - 31
IS  - 1
SP  - 21
VL  - 39
DO  - 10.1111/ijlh.12564
ER  - 

@article{
author = "Šefer, Dijana and Bižić-Radulović, Sandra and Kraguljac-Kurtović, Nada and Bogdanović, Andrija and Čokić, Vladan and Miljić, Predrag and Beleslin-Čokić, Bojana and Knežević, Vesna and Mitrović-Ajtić, Olivera and Leković, Danijela and Gotić, Mirjana",
year = "2017",
abstract = "Introduction: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are characterized by overproduction of one or more blood cell lines. Methods: We studied the proliferative characteristics of 91 patients with de novo Ph-MPN. Colony-forming cells (CFC) and endogenous colonies (EC), from bone marrow (BM) and/or peripheral blood (PB), were analyzed by colony assay based on methylcellulose. The level of circulating CD34(+) cells was determined by flow cytometry. Results: The total number of PB CFC in primary myelofibrosis (PMF) was increased compared to the control sample (P  lt  0.01) and essential thrombocythemia (ET) (P  lt  0.05). The highest number of BM and PB EC was observed in polycythemia vera (PV) (P  lt  0.01). Increased levels of CD34(+) cells characterized early-prefibrotic (57%) and advanced-fibrotic PMF (90%) as compared to PV (34%) and ET (32%) (P  lt  0.01). In the whole Ph-MPN group, the total number of PB CFC (P  lt  0.01), PB EC (P  lt  0.05), and CD34+ cells (P  lt  0.01) correlated with the degree of BM fibrosis. Higher levels of circulating CD34(+) cells in PMF correlated with the total number of PB EC (P  lt  0.05) and degree of BM fibrosis (P  lt  0.01). Conclusions: Exploration of the PB proliferative characteristics of Ph-MPN on diagnosis may be helpful in revealing early-prefibrotic PMF. Monitoring the levels of circulating CD34(+) cells may provide a sensitive indicator of fibrotic evolution in PV and PMF.",
publisher = "Wiley, Hoboken",
journal = "International Journal of Laboratory Hematology",
title = "Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications",
pages = "31-21",
number = "1",
volume = "39",
doi = "10.1111/ijlh.12564"
}

Šefer, D., Bižić-Radulović, S., Kraguljac-Kurtović, N., Bogdanović, A., Čokić, V., Miljić, P., Beleslin-Čokić, B., Knežević, V., Mitrović-Ajtić, O., Leković, D.,& Gotić, M.. (2017). Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications. in International Journal of Laboratory Hematology
Wiley, Hoboken., 39(1), 21-31.
https://doi.org/10.1111/ijlh.12564

Šefer D, Bižić-Radulović S, Kraguljac-Kurtović N, Bogdanović A, Čokić V, Miljić P, Beleslin-Čokić B, Knežević V, Mitrović-Ajtić O, Leković D, Gotić M. Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications. in International Journal of Laboratory Hematology. 2017;39(1):21-31.
doi:10.1111/ijlh.12564 .

Šefer, Dijana, Bižić-Radulović, Sandra, Kraguljac-Kurtović, Nada, Bogdanović, Andrija, Čokić, Vladan, Miljić, Predrag, Beleslin-Čokić, Bojana, Knežević, Vesna, Mitrović-Ajtić, Olivera, Leković, Danijela, Gotić, Mirjana, "Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications" in International Journal of Laboratory Hematology, 39, no. 1 (2017):21-31,
https://doi.org/10.1111/ijlh.12564 . .

TY  - CONF
AU  - Sefer, Dijana
AU  - Miljić, Predrag
AU  - Kraguljac-Kurtović, Nada
AU  - Bizic-Radulović, S.
AU  - Čokić, Vladan
AU  - Bogdanović, Andrija
AU  - Marković, Dragana
AU  - Knežević, V.
AU  - Leković, Danijela
AU  - Gotić, Mirjana
PY  - 2017
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/811
PB  - Ferrata Storti Foundation, Pavia
C3  - Haematologica
T1  - Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms
EP  - 546
SP  - 545
VL  - 102
UR  - https://hdl.handle.net/21.15107/rcub_rimi_811
ER  - 

@conference{
author = "Sefer, Dijana and Miljić, Predrag and Kraguljac-Kurtović, Nada and Bizic-Radulović, S. and Čokić, Vladan and Bogdanović, Andrija and Marković, Dragana and Knežević, V. and Leković, Danijela and Gotić, Mirjana",
year = "2017",
publisher = "Ferrata Storti Foundation, Pavia",
journal = "Haematologica",
title = "Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms",
pages = "546-545",
volume = "102",
url = "https://hdl.handle.net/21.15107/rcub_rimi_811"
}

Sefer, D., Miljić, P., Kraguljac-Kurtović, N., Bizic-Radulović, S., Čokić, V., Bogdanović, A., Marković, D., Knežević, V., Leković, D.,& Gotić, M.. (2017). Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms. in Haematologica
Ferrata Storti Foundation, Pavia., 102, 545-546.
https://hdl.handle.net/21.15107/rcub_rimi_811

Sefer D, Miljić P, Kraguljac-Kurtović N, Bizic-Radulović S, Čokić V, Bogdanović A, Marković D, Knežević V, Leković D, Gotić M. Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms. in Haematologica. 2017;102:545-546.
https://hdl.handle.net/21.15107/rcub_rimi_811 .

Sefer, Dijana, Miljić, Predrag, Kraguljac-Kurtović, Nada, Bizic-Radulović, S., Čokić, Vladan, Bogdanović, Andrija, Marković, Dragana, Knežević, V., Leković, Danijela, Gotić, Mirjana, "Monitoring of leukocyte-platelet aggregates and selectin levels in patients with philadelphia-negative myeloproliferative neoplasms" in Haematologica, 102 (2017):545-546,
https://hdl.handle.net/21.15107/rcub_rimi_811 .

TY  - CONF
AU  - Sefer, Dijana
AU  - Miljić, Predrag
AU  - Kraguljac-Kurtović, Nada
AU  - Bizic-Radulović, S.
AU  - Čokić, Vladan
AU  - Marković, Dragana
AU  - Beleslin-Čokić, Bojana
AU  - Novaković, I.
AU  - Erić-Marinković, Jelena
AU  - Leković, Danijela
AU  - Bodrozić, J.
AU  - Gotić, Mirjana
PY  - 2016
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/750
PB  - Ferrata Storti Foundation, Pavia
C3  - Haematologica
T1  - Predictive role of circulating leucocyte-platelet aggregates for thromboembolic complications in philadelphia-negative myeloproliferative neoplasms: a prospective study
EP  - 266
SP  - 266
VL  - 101
UR  - https://hdl.handle.net/21.15107/rcub_rimi_750
ER  - 

@conference{
author = "Sefer, Dijana and Miljić, Predrag and Kraguljac-Kurtović, Nada and Bizic-Radulović, S. and Čokić, Vladan and Marković, Dragana and Beleslin-Čokić, Bojana and Novaković, I. and Erić-Marinković, Jelena and Leković, Danijela and Bodrozić, J. and Gotić, Mirjana",
year = "2016",
publisher = "Ferrata Storti Foundation, Pavia",
journal = "Haematologica",
title = "Predictive role of circulating leucocyte-platelet aggregates for thromboembolic complications in philadelphia-negative myeloproliferative neoplasms: a prospective study",
pages = "266-266",
volume = "101",
url = "https://hdl.handle.net/21.15107/rcub_rimi_750"
}

Sefer, D., Miljić, P., Kraguljac-Kurtović, N., Bizic-Radulović, S., Čokić, V., Marković, D., Beleslin-Čokić, B., Novaković, I., Erić-Marinković, J., Leković, D., Bodrozić, J.,& Gotić, M.. (2016). Predictive role of circulating leucocyte-platelet aggregates for thromboembolic complications in philadelphia-negative myeloproliferative neoplasms: a prospective study. in Haematologica
Ferrata Storti Foundation, Pavia., 101, 266-266.
https://hdl.handle.net/21.15107/rcub_rimi_750

Sefer D, Miljić P, Kraguljac-Kurtović N, Bizic-Radulović S, Čokić V, Marković D, Beleslin-Čokić B, Novaković I, Erić-Marinković J, Leković D, Bodrozić J, Gotić M. Predictive role of circulating leucocyte-platelet aggregates for thromboembolic complications in philadelphia-negative myeloproliferative neoplasms: a prospective study. in Haematologica. 2016;101:266-266.
https://hdl.handle.net/21.15107/rcub_rimi_750 .

Sefer, Dijana, Miljić, Predrag, Kraguljac-Kurtović, Nada, Bizic-Radulović, S., Čokić, Vladan, Marković, Dragana, Beleslin-Čokić, Bojana, Novaković, I., Erić-Marinković, Jelena, Leković, Danijela, Bodrozić, J., Gotić, Mirjana, "Predictive role of circulating leucocyte-platelet aggregates for thromboembolic complications in philadelphia-negative myeloproliferative neoplasms: a prospective study" in Haematologica, 101 (2016):266-266,
https://hdl.handle.net/21.15107/rcub_rimi_750 .

TY  - JOUR
AU  - Leković, Danijela
AU  - Gotić, Mirjana
AU  - Milić, Nataša
AU  - Miljić, Predrag
AU  - Mitrović, Mirjana
AU  - Čokić, Vladan
AU  - Elezović, Ivo
PY  - 2014
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/550
AB  - The current widely accepted stratification defined by age and previous thrombosis in patients with essential thrombocythemia (ET) probably deserves deeper analysis. The aim of our study was to identify additional factors at the time of diagnosis, which have an impact on the thrombosis prediction. We conducted a study of 244 consecutive ET patients with median follow-up of 83 months. We analyzed the influence of age, gender, laboratory parameters, history of previous thrombosis, spleen size, JAK2 mutation as well as cardiovascular (CV) risk factors including arterial hypertension, diabetes, active tobacco use and hyperlipidemia in the terms of thrombosis. The most important predictors of thrombosis in multivariate Cox regression model were the presence of CV risk factors (p = 0.004) and previous thrombosis (p = 0.038). Accordingly, we assigned risk scores based on multivariable analysis-derived hazard ratios (HR) to the presence of 1 CV risk factor (HR = 3.5; 1 point),  gt 1 CV risk factors (HR = 8.3; 2 points) and previous thrombosis (HR = 2.0; 1 point). A final three-tiered prognostic model for thrombosis prediction was developed as low (score 0), intermediate (score 1 or 2) and high risk (score 3) (p  lt  0.001). The hazard of thrombosis was 3.8 % in low-risk group, 16.7 % in the intermediate-risk group and 60 % in the high-risk group (p  lt  0.001). Patients with thrombotic complications during the follow-up had a significantly shorter survival (p = 0.018). The new score based on CV risk factors and previous thrombotic events allows a better patient selection within prognostic-risk groups and improved identification of the high-risk patients for thrombosis.
PB  - Humana Press Inc, Totowa
T2  - Medical Oncology
T1  - The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia
IS  - 10
VL  - 31
DO  - 10.1007/s12032-014-0231-1
ER  - 

@article{
author = "Leković, Danijela and Gotić, Mirjana and Milić, Nataša and Miljić, Predrag and Mitrović, Mirjana and Čokić, Vladan and Elezović, Ivo",
year = "2014",
abstract = "The current widely accepted stratification defined by age and previous thrombosis in patients with essential thrombocythemia (ET) probably deserves deeper analysis. The aim of our study was to identify additional factors at the time of diagnosis, which have an impact on the thrombosis prediction. We conducted a study of 244 consecutive ET patients with median follow-up of 83 months. We analyzed the influence of age, gender, laboratory parameters, history of previous thrombosis, spleen size, JAK2 mutation as well as cardiovascular (CV) risk factors including arterial hypertension, diabetes, active tobacco use and hyperlipidemia in the terms of thrombosis. The most important predictors of thrombosis in multivariate Cox regression model were the presence of CV risk factors (p = 0.004) and previous thrombosis (p = 0.038). Accordingly, we assigned risk scores based on multivariable analysis-derived hazard ratios (HR) to the presence of 1 CV risk factor (HR = 3.5; 1 point),  gt 1 CV risk factors (HR = 8.3; 2 points) and previous thrombosis (HR = 2.0; 1 point). A final three-tiered prognostic model for thrombosis prediction was developed as low (score 0), intermediate (score 1 or 2) and high risk (score 3) (p  lt  0.001). The hazard of thrombosis was 3.8 % in low-risk group, 16.7 % in the intermediate-risk group and 60 % in the high-risk group (p  lt  0.001). Patients with thrombotic complications during the follow-up had a significantly shorter survival (p = 0.018). The new score based on CV risk factors and previous thrombotic events allows a better patient selection within prognostic-risk groups and improved identification of the high-risk patients for thrombosis.",
publisher = "Humana Press Inc, Totowa",
journal = "Medical Oncology",
title = "The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia",
number = "10",
volume = "31",
doi = "10.1007/s12032-014-0231-1"
}

Leković, D., Gotić, M., Milić, N., Miljić, P., Mitrović, M., Čokić, V.,& Elezović, I.. (2014). The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia. in Medical Oncology
Humana Press Inc, Totowa., 31(10).
https://doi.org/10.1007/s12032-014-0231-1

Leković D, Gotić M, Milić N, Miljić P, Mitrović M, Čokić V, Elezović I. The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia. in Medical Oncology. 2014;31(10).
doi:10.1007/s12032-014-0231-1 .

Leković, Danijela, Gotić, Mirjana, Milić, Nataša, Miljić, Predrag, Mitrović, Mirjana, Čokić, Vladan, Elezović, Ivo, "The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia" in Medical Oncology, 31, no. 10 (2014),
https://doi.org/10.1007/s12032-014-0231-1 . .

TY  - CONF
AU  - Leković, Danijela
AU  - Gotić, Mirjana
AU  - Milić, Nataša
AU  - Miljić, Predrag
AU  - Bogdanović, Andrija
AU  - Milošević, V.
AU  - Mitrović, M.
AU  - Čokić, Vladan
AU  - Elezović, Ivo
PY  - 2014
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/554
PB  - Ferrata Storti Foundation, Pavia
C3  - Haematologica
T1  - A prognostic model to predict thrombosis in essential thrombocythemia
EP  - 394
SP  - 394
VL  - 99
UR  - https://hdl.handle.net/21.15107/rcub_rimi_554
ER  - 

@conference{
author = "Leković, Danijela and Gotić, Mirjana and Milić, Nataša and Miljić, Predrag and Bogdanović, Andrija and Milošević, V. and Mitrović, M. and Čokić, Vladan and Elezović, Ivo",
year = "2014",
publisher = "Ferrata Storti Foundation, Pavia",
journal = "Haematologica",
title = "A prognostic model to predict thrombosis in essential thrombocythemia",
pages = "394-394",
volume = "99",
url = "https://hdl.handle.net/21.15107/rcub_rimi_554"
}

Leković, D., Gotić, M., Milić, N., Miljić, P., Bogdanović, A., Milošević, V., Mitrović, M., Čokić, V.,& Elezović, I.. (2014). A prognostic model to predict thrombosis in essential thrombocythemia. in Haematologica
Ferrata Storti Foundation, Pavia., 99, 394-394.
https://hdl.handle.net/21.15107/rcub_rimi_554

Leković D, Gotić M, Milić N, Miljić P, Bogdanović A, Milošević V, Mitrović M, Čokić V, Elezović I. A prognostic model to predict thrombosis in essential thrombocythemia. in Haematologica. 2014;99:394-394.
https://hdl.handle.net/21.15107/rcub_rimi_554 .

Leković, Danijela, Gotić, Mirjana, Milić, Nataša, Miljić, Predrag, Bogdanović, Andrija, Milošević, V., Mitrović, M., Čokić, Vladan, Elezović, Ivo, "A prognostic model to predict thrombosis in essential thrombocythemia" in Haematologica, 99 (2014):394-394,
https://hdl.handle.net/21.15107/rcub_rimi_554 .

TY  - CONF
AU  - Leković, Danijela
AU  - Gotić, Mirjana
AU  - Bogdanović, Andrija
AU  - Miljić, Predrag
AU  - Novaković, V.
AU  - Bogunović, M.
AU  - Peruničić, Maja
AU  - Sefer, Dijana
AU  - Đorđević, V.
AU  - Čokić, Vladan
PY  - 2012
UR  - http://rimi.imi.bg.ac.rs/handle/123456789/433
PB  - Ferrata Storti Foundation, Pavia
C3  - Haematologica
T1  - Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia
EP  - 637
SP  - 637
VL  - 97
UR  - https://hdl.handle.net/21.15107/rcub_rimi_433
ER  - 

@conference{
author = "Leković, Danijela and Gotić, Mirjana and Bogdanović, Andrija and Miljić, Predrag and Novaković, V. and Bogunović, M. and Peruničić, Maja and Sefer, Dijana and Đorđević, V. and Čokić, Vladan",
year = "2012",
publisher = "Ferrata Storti Foundation, Pavia",
journal = "Haematologica",
title = "Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia",
pages = "637-637",
volume = "97",
url = "https://hdl.handle.net/21.15107/rcub_rimi_433"
}

Leković, D., Gotić, M., Bogdanović, A., Miljić, P., Novaković, V., Bogunović, M., Peruničić, M., Sefer, D., Đorđević, V.,& Čokić, V.. (2012). Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia. in Haematologica
Ferrata Storti Foundation, Pavia., 97, 637-637.
https://hdl.handle.net/21.15107/rcub_rimi_433

Leković D, Gotić M, Bogdanović A, Miljić P, Novaković V, Bogunović M, Peruničić M, Sefer D, Đorđević V, Čokić V. Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia. in Haematologica. 2012;97:637-637.
https://hdl.handle.net/21.15107/rcub_rimi_433 .

Leković, Danijela, Gotić, Mirjana, Bogdanović, Andrija, Miljić, Predrag, Novaković, V., Bogunović, M., Peruničić, Maja, Sefer, Dijana, Đorđević, V., Čokić, Vladan, "Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia" in Haematologica, 97 (2012):637-637,
https://hdl.handle.net/21.15107/rcub_rimi_433 .